Investor Relations

Advanced therapies for the sports medicine and severe burn care markets

Day High:
Day Low:
Volume:
on
Data Provided by Refinitiv. Minimum 15 minutes delayed.

Investor Relations

Press Releases

May 8, 2024

Vericel Reports First Quarter 2024 Financial Results and Raises Full-Year 2024 Financial Guidance

April 24, 2024

Vericel to Report First-Quarter 2024 Financial Results on May 8, 2024

February 29, 2024

Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full-Year 2024 Financial Guidance

Events and Presentations

Upcoming Events
More events are coming soon.

 

 

Presentations
More information is coming soon.

Quarterly Results

Show all

Stock Quote & Analyst Coverage

Stock Quote ()

Change
Volume
Today's Open
Previous Close
Today's High
Today's Low
52 Week High
52 Week Low
Vericel Corporation is covered by the following analysts.
Ryan Zimmerman
BTIG
Swayampakula Ramakanth
H.C. Wainwright & Co.
Jeff Cohen
Ladenburg Thalmann
Mike Kratky
Leerink
George Sellers
Stephens
Samuel Brodovsky
Truist

Vericel Corporation is followed by the analysts listed. Please note that any opinions, estimates or forecasts regarding Vericel Corporation's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Vericel Corporation or its management. Vericel Corporation does not by its reference or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.